Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment

Genome Research

Volumn 23, Issue 7, 2013, Pages 1155-1162

  Snitkin, Evan S ^a   Zelazny, Adrian M ^b   Gupta, Jyoti ^c   Palmore, Tara N ^b   Murray, Patrick R ^b   Segre, Julia A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COLISTIN; PMR PROTEIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENETIC FITNESS; GENOME, BACTERIAL; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880049802     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.154328.112     Document Type: Article

References (45)

1. Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 53: 3628-3634.
2. Alekshun M, Levy S. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128: 1037-1050.
3. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat Rev Microbiol 8: 260-271.
4. Andersson DI, Levin BR. 1999. The biological cost of antibiotic resistance. Curr Opin Microbiol 2: 489-493.
5. Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, et al. 2011. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 365: 892-900.
6. Arroyo LA, Garcia-Curiel A, Pachon-Ibanez ME, Llanos AC, Ruiz M, Pachon J, Aznar J. 2005. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43: 903-905.
7. Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, et al. 2011. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB twocomponent regulatory system. Antimicrob Agents Chemother 55: 3370-3379.
8. Brogden KA. 2005. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
9. Cai Y, Chai D, Wang R, Liang B, Bai N. 2012. Colistin resistance of Acinetobacter baumannii: Clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 67: 1607-1615.
10. Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M, Galagan J, Niemann S, Gagneux S. 2012. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 44: 106-110.
11. Delcher AL, Phillippy A, Carlton J, Salzberg SL. 2002. Fast algorithms for large-scale genome alignment and comparison. Nucleic Acids Res 30: 2478-2483.
12. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5: 939-951.
13. Fernández-Reyes M, Rodríguez-Falcón M, Chiva C, Pachón J, Andreu D, Rivas L. 2009. The cost of resistance to colistin in Acinetobacter baumannii: A proteomic perspective. Proteomics 9: 1632-1645.
14. Fouts DE. 2006. Phage-Finder: Automated identification and classification of prophage regions in complete bacterial genome sequences. Nucleic Acids Res 34: 5839-5851.
15. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJM. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312: 1944-1946.
16. Gales AC, Jones RN, Sader HS. 2011. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 66: 2070-2074.
17. Gordon NC, Wareham DW. 2010. Multidrug-resistant Acinetobacter baumannii: Mechanisms of virulence and resistance. Int J Antimicrob Agents 35: 219-226.
18. Gordon D, Abajian C, Green P. 1998. Consed: A graphical tool for sequence finishing. Genome Res 8: 195-202.
19. Hall BM, Ma C-X, Liang P, Singh KK. 2009. Fluctuation AnaLysis CalculatOR: A web tool for the determination of mutation rate using Luria-Delbrück fluctuation analysis. Bioinformatics 25: 1564-1565.
20. Hermsen R, Deris JB, Hwa T. 2012. On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proc Natl Acad Sci 109: 10775-10780.
21. Howden BP, McEvoy CRE, Allen DL, Chua K, Gao W, Harrison PF, Bell J, Coombs G, Bennett-Wood V, Porter JL, et al. 2011. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulatorWalKR. PLoS Pathog 7: e1002359.
22. Hsing W, Russo FD, Bernd KK, Silhavy TJ. 1998. Mutations that alter the kinase and phosphatase activities of the two-component sensor EnvZ. J Bacteriol 180: 4538-4546.
23. Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: From targets to networks. Nat Rev Microbiol 8: 423-435.
24. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5: 48-56.
25. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV. 2007. Antimicrobial resistance among Gramnegative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 45: 3352-3359.
26. Loman NJ, Constantinidou C, Chan JZM, Halachev M, Sergeant M, Penn CW, Robinson ER, Pallen MJ. 2012. High-throughput bacterial genome sequencing: An embarrassment of choice, a world of opportunity. Nat Rev Microbiol 10: 599-606.
27. López-Rojas R, Domínguez-Herrera J, McConnell MJ, Docobo-Peréz F, Smani Y, Fernández-Reyes M, Rivas L, Pachón J. 2011. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 203: 545-548.
28. Martínez-Hackert E, Stock AM. 1997. The DNA-binding domain of OmpR: Crystal structures of a winged helix transcription factor. Structure 5: 109-124.
29. Moffatt JH, Harper M, Harrison P, Hale JDF, Vinogradov E, Seemann T, Henry R, Crane B, St. Michael F, Cox AD, et al. 2010. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 54: 4971-4977.
30. Munoz-Price LS, Weinstein RA. 2008. Acinetobacter infection. N Engl J Med 358: 1271-1281.
31. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, De Lencastre H, Richardson P, Bruce D, Rubin E, Myers E, Siggia ED, et al. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by wholegenome sequencing. Proc Natl Acad Sci 104: 9451-9456.
32. Ng PC, Henikoff S. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814.
33. Nielsen KL, Pedersen TM, Udekwu KI, Petersen A, Skov RL, Hansen LH, Hughes D, Frimodt-Møller N. 2012. Fitness cost: A bacteriological explanation for the demise of the first international methicillinresistant Staphylococcus aureus epidemic. J Antimicrob Chemother 67: 1325-1332.
34. Palmore TN, Michelin AV, Bordner M, Odom RT, Stock F, Sinaii N, Fedorko DP, Murray PR, Henderson DK. 2011. Use of adherence monitors as part of a team approach to control clonal spread of multidrug-resistant Acinetobacter baumannii in a research hospital. Infect Control Hosp Epidemiol 32: 1166-1172.
35. Park YK, Choi JY, Shin D, Ko KS. 2011. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int J Antimicrob Agents 37: 525-530.
36. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51: 3471-3484.
37. Rissman AI, Mau B, Biehl BS, Darling AE, Glasner JD, Perna NT. 2009. Reordering contigs of draft genomes using the Mauve Aligner. Bioinformatics 25: 2071-2073.
38. Rolain J-M, Roch A, Castanier M, Papazian L, Raoult D. 2011. Acinetobacter baumannii resistant to colistin with impaired virulence: A case report from France. J Infect Dis 204: 1146-1147.
39. Rolain J-M, Diene SM, Kempf M, Gimenez G, Robert C, Raoult D. 2012. Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France. Antimicrob Agents Chemother 57: 592-596.
40. Rosche WA, Foster PL. 2000. Determining mutation rates in bacterial populations. Methods 20: 4-17.
41. Saunders NJ, Trivedi UH, Thomson ML, Doig C, Laurenson IF, Blaxter ML. 2011. Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. J Infect 62: 212-217.
42. Snitkin ES, Zelazny AM, Montero CI, Stock F, Mijares L, NISC Comparative Sequence Program, Murray PR, Segre JA. 2011. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci 108: 13758-13763.
43. Sun G, Luo T, Yang C, Dong X, Li J, Zhu Y, Zheng H, TianW, Wang S, Barry CE, et al. 2012. Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J Infect Dis 206: 1724-1733.
44. Valencia R, Arroyo LA, Conde M, Aldana JM, Torres M, Fernández- Cuenca F, Garnacho-Montero J, Cisneros JM, Ortíz C, Pachón J, et al. 2009. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 30: 257-263.
45. Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR, Church GM. 2009. Programming cells by multiplex genome engineering and accelerated evolution. Nature 460: 894-898.